FDA perspectives on postmarket surveillance of peripheral and aortic vascular devices
Misti Malone1, Carmen Gacchina Johnson1
1Office of Cardiovascular Devices, Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, Maryland, USA.
Abstract
No abstract available in PubMed .


